Skip to main content
Clinical Trials/NCT02274974
NCT02274974CompletedPhase 4

Post-Caesarean Section Incisional Infiltration With Lidocaine Versus Lidocaine and Epinephrine;Randomized Controlled Trial.

Ain Shams Maternity Hospital1 site in 1 country160 target enrollmentStarted: August 2014Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
160
Locations
1
Primary Endpoint
Timing of first analgesic request.

Study Overview

Brief Summary

Study to compare between efficacy of post-caesarean section infiltration with lidocaine and epinephrine versus lidocaine only to reduce post-incisional pain.

Detailed Description

assessment of adding of epinephrine to lidocaine as local infiltrator to post-caesarean section wound in prolongation of its anaesthetic effect.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Screening
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 38 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Women undergoing caesarean delivery under General anesthesia for various indications.
  • Women refuse spinal anesthesia.

Exclusion Criteria

  • Known or suspected sensitivity to local anesthesia.
  • Medical disorders induced by pregnancy (Pre-eclamptic toxemia, gestational diabetes mellitus, Hepatic diseases, homeostatic disorder)
  • Medical disorders aggravated by pregnancy (cardiovascular disease, pulmonary disease, renal disease, neurological disease, metabolic or infectious diseases).
  • Women who hemo-dynamically unstable.
  • Lack of adequate verbal communication.

Arms & Interventions

lidocaine

Active Comparator

20 ml of 2% lidocaine.

Intervention: Lidocaine (Drug)

lidocaine and epinephrine.

Experimental

20 ml of 2% lidocaine and epinephrine in related dose manner 1:200.000. I.e.: by adding 1/4 from ampoule of adrenaline 1mg./1ml to bottle of lidocaine Hydrochloric acid (HCL) 2% 50 ml(20mg/ml).

Intervention: lidocaine and Epinephrine (Drug)

Outcomes

Primary Outcomes

Timing of first analgesic request.

Time Frame: 24 hours

Secondary Outcomes

  • Side effects of local infiltration of lidocaine and epinephrine(7 days)
  • Postoperative pyrexia(24 hours)
  • Duration of hospital stay(24 hours to 48 hours)
  • Duration of cesarean section(30 min to 90 min)
  • Onset of mobilization(24 hours)
  • Onset of breast breastfeeding(24 hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

AMR HELMY YEHIA

Lecturer in Obstetrics and Gynaecology

Ain Shams Maternity Hospital

Study Sites (1)

Loading locations...

Similar Trials